• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EPIX THERAPEUTICS DIAMONDTEMP¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EPIX THERAPEUTICS DIAMONDTEMP¿; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Model Number CEDTB400L
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Low Blood Pressure/ Hypotension (1914); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Date 03/15/2022
Event Type  Injury  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported that approximately five months following a radiofrequency (rf) ablation procedure, the patient developed recurrent atrial fibrillation (af).An electrocardiogram (ecg) was performed and it was observed that the patient also had an atrial flutter.The physician noted that the atrial flutter was not related the previous ablation and not related to the previous ablation devices.Approximately three months after the recurrent atrial fibrillation (af) was diagnosed, the patient had another radiofrequency (rf) ablation procedure.After the procedure was completed, the patient had chest pain and felt sick.The patient had hypotension and a pericardial effusion and tamponade were identified via electrocardiogram (ecg).Pericardiocentesis was performed.Anti-inflammatory medication was given.The physician noted that the pericardial effusion was probably due to the manipulation of the other diagnostic catheters.The patient's hospitalization was extended.The patient is a participant in a clinical study.No further patient complications have been reported as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DIAMONDTEMP¿
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
EPIX THERAPEUTICS
945 stewart drive
suite 100
sunnyvale CA 94085
Manufacturer (Section G)
EPIX THERAPEUTICS
945 stewart drive
suite 100
sunnyvale CA 94085
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key17420760
MDR Text Key320037045
Report Number3015180993-2023-00018
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P200028
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/28/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/22/2022
Device Model NumberCEDTB400L
Device Catalogue NumberCEDTB400L
Device Lot Number0000223577
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/28/2023
Date Device Manufactured10/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
2ACH20 - MAPPING CATHETER, 4FC12 - SHEATH
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age54 YR
Patient SexMale
Patient Weight90 KG
-
-